» Articles » PMID: 28386289

Sodium Tanshinone IIA Sulfonate Prevents Radiation-Induced Toxicity in H9c2 Cardiomyocytes

Overview
Date 2017 Apr 8
PMID 28386289
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The present study was designed to elucidate the key parameters associated with X-ray radiation induced oxidative stress and the effects of STS on X-ray-induced toxicity in H9c2 cardiomyocytes. Cytotoxicity of STS and radiation was assessed by MTT. Antioxidant activity was evaluated by SOD and MDA. Apoptosis was measured by the flow cytometry, Hoechst 33258, clonogenic survival assay, and western blot. It was found that the cell viability of H9c2 cells exposed to X-ray radiation was significantly decreased in a dose-dependent manner and was associated with cell cycle arrest at the G0/G1 phase as well as apoptosis. STS treatment significantly reversed the morphological changes, attenuated radiation-induced apoptosis, and improved the antioxidant activity in the H9c2 cells. STS significantly increased the Bcl-2 and Bcl-2/Bax levels and decreased the Bax and caspase-3 levels, compared with the cells treated with radiation alone. STS treatment also resulted in a significant increase in p38-MAPK activation. STS could protect the cells from X-ray-induced cell cycle arrest, oxidative stress, and apoptosis. Therefore, we suggest the STS could be useful for the treatment of radiation-induced cardiovascular injury.

Citing Articles

Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy.

Lv X, Wen R, Liu K, Zhao X, Pan C, Gao X Front Cardiovasc Med. 2022; 9:1047700.

PMID: 36419486 PMC: 9678083. DOI: 10.3389/fcvm.2022.1047700.


Tanshinone IIA Accomplished Protection against Radiation-Induced Cardiomyocyte Injury by Regulating the p38/p53 Pathway.

Wang G, Ma L, Wang B, Gao F, Li J, Cai H Mediators Inflamm. 2022; 2022:1478181.

PMID: 36046762 PMC: 9424041. DOI: 10.1155/2022/1478181.


Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension.

Bao Y, Chen J, Jiang Y, Wang L, Xue R, Qian J Front Pharmacol. 2020; 11:687.

PMID: 32508639 PMC: 7253651. DOI: 10.3389/fphar.2020.00687.


Protective effect of bacterial lipase on lipopolysaccharide-induced toxicity in rat cardiomyocytes; H9C2 cell line.

Mamipour M, Yousefi M, Dehnad A, Faridvand Y, Zarezadeh R, Khaksar M J Cardiovasc Thorac Res. 2020; 12(1):35-42.

PMID: 32211136 PMC: 7080329. DOI: 10.34172/jcvtr.2020.06.


in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications.

Ren J, Fu L, Nile S, Zhang J, Kai G Front Pharmacol. 2019; 10:753.

PMID: 31338034 PMC: 6626924. DOI: 10.3389/fphar.2019.00753.


References
1.
Armstrong G, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson M . Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 2014; 32(12):1218-27. PMC: 3986385. DOI: 10.1200/JCO.2013.51.1055. View

2.
Yang R, Liu A, Ma X, Li L, Su D, Liu J . Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. J Cardiovasc Pharmacol. 2008; 51(4):396-401. DOI: 10.1097/FJC.0b013e3181671439. View

3.
Xu H, Chen K . Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chin J Integr Med. 2011; 17(2):83-4. DOI: 10.1007/s11655-011-0641-2. View

4.
Harake D, Franco V, Henkel J, Miller T, Lipshultz S . Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol. 2012; 8(4):647-70. PMC: 3870660. DOI: 10.2217/fca.12.44. View

5.
Lipshultz S, Lipsitz S, Sallan S, Simbre 2nd V, Shaikh S, Mone S . Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol. 2002; 20(23):4517-22. DOI: 10.1200/JCO.2002.12.102. View